Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-08 Sale | 2021-01-12 4:12 pm | Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer | 8,505 | $15.79 | $134,271 | 5,761 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-02 4:39 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 21,428 | $2.8 | 59,937 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:21 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 16,968 | $0 | 55,477 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 4:44 pm | N/A 2032-05-31 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 13,222 | $0 | 51,731 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-03 4:21 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 16,773 | $3.58 | 38,509 (Direct) | View |
| 2021-11-17 Disposition | 2021-11-19 1:29 pm | N/A 2030-12-23 | Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer | 461,385 | $0 | 0 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-16 4:45 pm | N/A 2031-07-14 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 9,393 | $0 | 31,340 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:12 pm | N/A 2026-11-09 | Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer | 8,505 | $0 | 5,761 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:12 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer | 8,505 | $7.2447 | 5,761 (Direct) | View |
Ownership | 2021-01-04 8:21 pm | N/A 2030-12-23 | Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer | 0 | $0 | 469,890 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-04 4:21 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 7,745 | $8.23 | 21,947 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 4:49 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 8,102 | $4.59 | 27,508 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 4:49 pm | N/A 2030-05-31 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 13,306 | $0 | 27,508 (Direct) | View |
| 2019-06-24 Option Award | 2019-06-26 4:36 pm | N/A 2029-06-23 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 12,950 | $0 | 19,050 (Direct) | View |